Leaflet: information for the user
Calmagrip Forte oral powder for solution
Paracetamol/cafeine/clorfenamina maleate
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
Follow exactly the administration instructions for the medicine contained in this leaflet or those indicated by your doctor or pharmacist.
Contents of the pack and additional information
Calmagrip Forte is a combination of paracetamol (a pain reliever that reduces pain and fever), chlorphenamine maleate (an antihistamine that relieves nasal discharge) and caffeine.
This medication is indicated for symptomatic relief of catarrhal and flu-like processes that are accompanied by fever, mild to moderate pain (such as headache), tearing, and sneezingfor adults and adolescents 14 years and older.
Consult a doctor if symptoms worsen or do not improve after 5 days of treatment (3 days for fever and for adolescents).
Do not take Calmagrip Forte
Warnings and precautions
Consult your doctor or pharmacist before starting to take Calmagrip Forte.
Use in children
Do not use in children under 14 years old.
Other medications and Calmagrip Forte
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Take note that these instructions may also apply to medications that have been used before or may be used afterwards.
Do not use this medication with other medications containing paracetamol, as high doses may cause liver damage. Do not use more than one medication containing paracetamol without consulting your doctor.
Particularly, if you are using any of the following medications, you may need to modify the dose of some of them or discontinue treatment:
Interference with diagnostic tests
Inform your doctor if you are to undergo any diagnostic test (including blood, urine, etc...) as this medication may alter the results.
This medication may interfere with uric acid levels in the blood.
This medication may interfere with skin tests that use allergens. It is recommended to discontinue taking this medication at least three days before starting the tests and inform your doctor.
Taking Calmagrip Forte with food, drinks, and alcohol
The use of Calmagrip Forte in patients who regularly consume alcohol (three or more alcoholic beverages per day) may cause liver damage.
The simultaneous use of this medication with caffeine-containing beverages may cause nervousness, irritability, or insomnia.
The simultaneous use of this medication with alcoholic beverages may cause an interaction with the antihistamine (chlorphenamine) it contains, potentiating the sedative effects.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
IMPORTANT FOR WOMEN
If you are pregnant or think you may be pregnant, consult your doctor before taking this medication. Taking medications during pregnancy can be hazardous to the embryo or fetus and should be monitored by your doctor.
Breastfeeding
Consult your doctor or pharmacist before taking a medication.
The active ingredients of Calmagrip Forte pass into breast milk. Women breastfeeding, should avoid taking this medication without consulting their doctor.
Driving and operating machinery
Avoid performing activities that require great attention, such as driving cars or operating machinery that may be hazardous, as this medication may cause drowsiness.
Important information about some components of Calmagrip Forte
This medication contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Calmagrip Forte is taken orally.
The contents of the packet are taken dissolved in half a glass of water.
Adults and children over 14 years old:1 packet every 6-8 hours. Do not take more than3 gevery 24 hours (1 day).
Patients with kidney or liver diseases: They must consult their doctor.
Over 65 years old: Before taking this medication, they must consult their doctor because they may need lower doses due to being more sensitive to the adverse effects of chlorphenamine.
The administration of this medication is subject to the appearance of symptoms. As these symptoms disappear, this medication should be discontinued.
If the fever lasts more than 3 days, or the symptoms worsen or do not improve after 5 days, or other symptoms appear, interrupt the treatment and consult your doctor.
Always use the lowest effective dose.
If you estimate that the action of Calmagrip Forte is too strong or too weak, inform your doctor or pharmacist.
If you take more Calmagrip Forte than you should
If you have taken more Calmagrip Forte than you should, consult your doctor or pharmacist immediately.
If an overdose has been ingested, go quickly to a medical center, even if there are no symptoms, as they often do not appear until 3 days after the ingestion of the overdose, even in cases of severe poisoning.
The symptoms of an overdose may be: dizziness, vomiting, loss of appetite, dry mouth, difficulty urinating, drowsiness, insomnia, restlessness (nervous overexcitement), yellowing of the skin and eyes (jaundice), and abdominal pain.
The treatment of an overdose is more effective if it is initiated within 4 hours of the ingestion of the medication.
Patients undergoing barbiturate treatment or chronic alcoholics may be more susceptible to the toxicity of a paracetamol overdose.
In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicological Information Service, Telephone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Calmagrip Forte
Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Calmagrip Forte
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may produce adverse effects, although not everyone will experience them.
Due to its paracetamol content, in rare instances (more than 1 in 10,000 patients but less than 1 in 1,000 patients), the following may occur: Kidney disorders, cloudy urine, allergic dermatitis (skin rash), jaundice (yellow discoloration of the skin), blood disorders (agranulocytosis, leucopenia, neutropenia, thrombocytopenia, hemolytic anemia) and hypoglycemia (low blood sugar). Paracetamol can damage the liver when taken in high doses or for prolonged periods. Rarely, severe skin reactions have been reported.
During the period of use of chlorphenamine, the following adverse effects have been observed, whose frequency has not been established with precision:
Drowsiness, sedation.
Dry mouth and throat (these effects are more likely to occur in elderly patients).
Gastrointestinal discomfort, nausea, vomiting, diarrhea, constipation (these effects can be prevented by taking the medication with milk or food).
Skin rashes.
Rarely, the following have been observed: Blurred vision, confusion, urinary retention, difficulty or pain during urination, (especially in elderly patients), loss of appetite. A paradoxical effect of excitement, nervousness, nightmares, has been observed, especially in children and elderly patients. Blood disorders, increased sweating, tachycardia.
During the period of use of caffeine, the following adverse effects have been observed, whose frequency has not been established with precision:
Nervousness, restlessness, stomach or intestinal irritation, tachycardia.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them through the national notification system Spanish System of Pharmacovigilance of Medicines for Human Use: www.notificaRAM.es.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 30 °C.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection point(or any other medication waste collection system) at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Calmagrip Forte:
Sodium saccharin and sodium cyclamate contribute 18.8 mg of sodium.
Appearance of the product and contents of the packaging
Calmagrip Forte is an oral powder solution, white-yellowish in color with an orange flavor. It is presented in 10 sachets.
Holder of the marketing authorization
PHARMEX ADVANCED LABORATORIES, S.L.
Ctra. A-431 Km.19
(Almodóvar del Río) -14720 -Spain
Responsible for manufacturing
ALCALÁ FARMA, S.L.
Avda. de Madrid, 82
28802 Alcalá de Henares (Madrid)
This leaflet was approved in May 2022
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.